WW International, Inc., known as WeightWatchers, announced that William Shrank, MD, MSHS, Venture Partner of Bio and Health at Andreessen Horowitz, and former Chief Medical Officer at Humana, has been appointed to the WeightWatchers Board of Directors, effective as of August 5, 2023. Dr. Shrank?s appointment follows the recent elections of Tara Comonte, board member of Strava and former CEO and current board member of TMRW Life Sciences, Inc., and Tracey Brown, EVP and President of Retail and U.S. Chief Customer Officer at Walgreens and the former CEO of the American Diabetes Association. Dr. William Shrank is serving as Venture Partner, Bio and Health at Andreessen Horowitz.

Previously, Dr. Shrank served as Chief Medical Officer for Humana, where his responsibilities included implementing Humana?s integrated care delivery strategy, with an emphasis on advancing the Company?s clinical capabilities and core objective of improving the health outcomes. He led Humana?s Care Delivery Organization, clinical operations, health equity, and the Bold Goal population health strategy. Dr. Shrank previously held the position of Chief Medical and Corporate Affairs Officer (July 2019-July 2021) during which time he oversaw government affairs.

Dr. Shrank joined Humana in April 2019, having previously been employed by the University of Pittsburgh Medical Center (UPMC) where he served as Chief Medical Officer, Insurance Services Division from 2016 to 2019. At UPMC, Dr. Shrank was responsible for clinical operations, policy and quality for approximately 3.5 million members in Medicare, Medicaid, behavioral health, Managed Long Term Social Supports and commercial lines of business. He also developed and evaluated population health programs to further advance the medical center?s mission as an integrated delivery and financing system.

Previously, Dr. Shrank served as Senior Vice President, Chief Scientific Officer, and Chief Medical Officer of Provider Innovation at CVS Health from 2013 to 2016. Prior to joining CVS Health, Dr. Shrank served as Director, Research and Rapid-Cycle Evaluation Group, for the Center for Medicare and Medicaid Innovation, part of the Centers for Medicaid and Medicare Services (CMS) from 2011 to 2013, where he led the evaluation of all payment and health system delivery reform programs and developed the rapid-cycle strategy to promote continuous quality improvement. Dr. Shrank began his career as a practicing physician with Brigham and Women?s Hospital in Boston and as an Assistant Professor at Harvard Medical School.

His research at Harvard focused on improving the quality of prescribing and the use of chronic medications. He has published more than 275 papers on these topics.